The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ID: ALA5202202
Max Phase: Preclinical
Molecular Formula: C21H21N5O3
Molecular Weight: 391.43
Associated Items:
Representations Canonical SMILES: O=C1NC(Nc2ccc(N3CCNCC3)cc2)=N/C1=C\c1ccc2c(c1)OCO2
Standard InChI: InChI=1S/C21H21N5O3/c27-20-17(11-14-1-6-18-19(12-14)29-13-28-18)24-21(25-20)23-15-2-4-16(5-3-15)26-9-7-22-8-10-26/h1-6,11-12,22H,7-10,13H2,(H2,23,24,25,27)/b17-11-
Standard InChI Key: JBFOGRDEYAYPMV-BOPFTXTBSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Properties Molecular Weight: 391.43Molecular Weight (Monoisotopic): 391.1644AlogP: 1.76#Rotatable Bonds: 3Polar Surface Area: 87.22Molecular Species: BASEHBA: 7HBD: 3#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 0CX Acidic pKa: 9.92CX Basic pKa: 8.87CX LogP: 1.82CX LogD: 0.61Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.69Np Likeness Score: -0.73
References 1. Tahtouh T, Durieu E, Villiers B, Bruyère C, Nguyen TL, Fant X, Ahn KH, Khurana L, Deau E, Lindberg MF, Sévère E, Miege F, Roche D, Limanton E, L'Helgoual'ch JM, Burgy G, Guiheneuf S, Herault Y, Kendall DA, Carreaux F, Bazureau JP, Meijer L.. (2022) Structure-Activity Relationship in the Leucettine Family of Kinase Inhibitors., 65 (2.0): [PMID:34928152 ] [10.1021/acs.jmedchem.1c01141 ]